Background: In areas with high clarithromycin resistance, bismuth quadruple therapy (BQT)
is recommended instead of clarithromycin triple therapy (CTT) as the first-line treatment for …

Background Concomitant quadruple (CQT) or bismuth‐containing quadruple therapy (BQT)
is recommended as first‐line treatment for Helicobacter pylori infection depending on …

OBJECTIVES: Recent treatment guidelines recommend two first-line therapies
forHelicobacter pyloriinfection: proton pump inhibitor (PPI), bismuth, tetracycline, and …

Background: The success rate of currently recommended 7‐day triple therapy with a PPI
plus amoxicillin and clarithromycin has fallen into the unacceptable range. It is urgent to look …

The efficacy of triple therapy for Helicobacter pylori infection has dramatically declined over
the last decade, largely related to increasing clarithromycin resistance rates. From a …

Objective Bismuth‐containing quadruple therapy for Helicobacter pylori (H. pylori)
eradication has a relatively high rate of side effects and high cost, thus the option of a high …

Aim To compare the efficacy and safety between modified quadruple-and bismuth-
containing quadruple therapy as first-line eradication regimen for Helicobacter pylori …

Background Whether concomitant therapy is superior to bismuth quadruple therapy or 14-
day triple therapy for the first-line treatment of Helicobacter pylori infection remains poorly …

Background With markedly increased antibiotic resistance and unsatisfactory efficacies of
common empiric eradication regimens in the mainland of China, tailored therapy may be the …

BACKGROUND: Helicobacter pylori eradication rates have tended to decrease recently,
mostly due to increasing antibiotic‐resistance. The present study aimed to compare the …